Seqens Seqens

X
[{"orgOrder":0,"company":"Lupin Ltd","sponsor":"Not Applicable","pharmaFlowCategory":"DU","amount":"Not Applicable","upfrontCash":"Not Applicable","newsHeadline":"Pharma Major Lupin Launches Injection to Cure Thiamine Deficiency in US","therapeuticArea":"Nutrition and Weight Loss","highestDevelopmentStatus":"Approved","country":"INDIA","productType":"Small molecule","productStatus":"Approved","date":"June 2023","url1":"","url2":"","graph1":"Nutrition and Weight Loss","graph2":"Approved"}]

Find Clinical Drug Pipeline Developments & Deals for Thiamine Hydrochloride

Menu
Loading...
Filters Filter
×
FILTER:
filter Company
    filter Sponsor
      filter Country
        filter Therapeutic Area
          filter Study Phase

            Active Filter(s):

            Companies By Therapeutic Area

            Development Status

            Details:

            Thiamine hydrochloride injection, is a water-soluble vitamin belonging to the B vitamin group, exhibits several noteworthy properties that is used for the treatment of thiamine deficiency.

            Lead Product(s): Thiamine Hydrochloride

            Therapeutic Area: Nutrition and Weight Loss Product Name: Thiamine Hydrochloride-Generic

            Highest Development Status: Approved Product Type: Small molecule

            Partner/Sponsor/Collaborator: Not Applicable

            Deal Size: Not Applicable Upfront Cash: Not Applicable

            Deal Type: Not Applicable June 19, 2023

            ASK
            US
            PHARMACOMPASS
            Upload
            your Pipeline Activity
            Close
            4
            Post Enquiry
            POST ENQUIRY